###begin article-title 0
###xml 97 106 <span type="species:ncbi:7955">zebrafish</span>
The small molecule Mek1/2 inhibitor U0126 disrupts the chordamesoderm to notochord transition in zebrafish
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mek1-/-</italic>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mek2-/-</italic>
###xml 114 123 <span type="species:ncbi:7955">zebrafish</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Key molecules involved in notochord differentiation and function have been identified through genetic analysis in zebrafish and mice, but MEK1 and 2 have so far not been implicated in this process due to early lethality (Mek1-/-) and functional redundancy (Mek2-/-) in the knockout animals.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 186 193 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Here, we reveal a potential role for Mek1/2 during notochord development by using the small molecule Mek1/2 inhibitor U0126 which blocks phosphorylation of the Mek1/2 target gene Erk1/2 in vivo. Applying the inhibitor from early gastrulation until the 18-somite stage produces a specific and consistent phenotype with lack of dark pigmentation, shorter tail and an abnormal, undulated notochord. Using morphological analysis, in situ hybridization, immunhistochemistry, TUNEL staining and electron microscopy, we demonstrate that in treated embryos the chordamesoderm to notochord transition is disrupted and identify disorganization in the medial layer of the perinotochordal basement mebrane as the probable cause of the undulations and bulges in the notochord. We also examined and excluded FGF as the upstream signal during this process.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Using the small chemical U0126, we have established a novel link between MAPK-signaling and notochord differentiation. Our phenotypic analysis suggests a potential connection between the MAPK-pathway, the COPI-mediated intracellular transport and/or the copper-dependent posttranslational regulatory processes during notochord differentiation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 377 385 377 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1281 1282 1281 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1558 1559 1555 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1560 1561 1557 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1682 1683 1679 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1684 1685 1681 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1045 1055 <span type="species:ncbi:7227">Drosophila</span>
###xml 1060 1069 <span type="species:ncbi:7955">zebrafish</span>
One of the greatest challenges in developmental biology is to bridge the gap between cell biology and experimental developmental genetics (ie. to link the function of a protein at the level of cell and organism). In order to achieve this, one has to use the methods, tools and results offered by other research fields. For developmental biologists, one possibility is to start in vivo testing of small molecules identified in chemical array experiments once their specificity is satisfactorily established in biochemical and cell culture assays. The use of such specific chemicals could identify functions of a protein obscured by early lethality in knockout or transgenic animals or by functional redundancy due to the activity of paralogous genes. This approach is also attractive as small molecules/drugs can be applied and withdrawn at will, providing an alternative for expensive and time-consuming transgenic experiments. The use of signaling pathway modifying chemicals is particularly feasible in classic genetic model organisms such as Drosophila and zebrafish, due to their relative cheapness and the availability of large numbers of externally and quickly developing embryos which allows rapid and parallel testing of various concentrations and application time points [1]. Recently several chemicals have been tested which are now widely used as inhibitors of certain pathways in developmental studies (eg. SU5402-fibroblast growth factor (FGF) signaling pathway, cyclopamine-hedgehog (Hh) signaling pathway, SB-431542-TGFbeta signaling pathway [2-6]). Moreover, large-scale small molecule screens have been carried out to identify potential drugs for various diseases [7,8].
###end p 9
###begin p 10
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 787 796 787 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1211 1213 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1314 1322 1314 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1335 1343 1335 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1477 1479 1477 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1480 1482 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1506 1508 1506 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1509 1511 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1536 1538 1536 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1563 1565 1563 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1668 1670 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1671 1673 1671 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1676 1684 1676 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 1922 1924 1922 1924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1925 1927 1925 1927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1743 1762 <span type="species:ncbi:7729">Halocynthia roretzi</span>
###xml 1767 1785 <span type="species:ncbi:7719">Ciona intestinalis</span>
The compound U0126 (1,4-diamino-2,3-dicyano-1,4-bis [2-aminophenylthio]butadiene) was originally identified as an inhibitor of AP-1 transactivation in a cell-based reporter assay [9]. This inhibition turned out to be due to direct and specific inhibition of the mitogen-activated protein kinase kinase (MAPKK) family members, MEK1 and MEK2. The MAPK pathway is one of the most thoroughly characterized intracellular signaling pathways transmitting extracellular signals (eg. growth, stress or differentiation factors) [10-12]. It has been implicated in various processes including cell proliferation, survival and differentiation [13] as well as in development [14]. Currently there are 6 known MAPK signaling pathways: (ERK1/2, ERK3/4, ERK5, ERK7/8, JNK1/2/3 and p38/ERK6) and although in vitro studies have described biochemical characteristics of these cascades in detail, their diverse (or redundant) roles during vertebrate development have only recently come under scrutiny [15-17]. Inhibitory activity of U0126 is selective for MEK1 and MEK2, and shows very little, if any, effect on the kinase activities of other protein kinases like c-Abl, Raf, MEKK, ERK, JNK, MKK-3, MKK-4/SEK, MKK-6, Cdk2, or Cdk4 [18]. Since its description, more than 1500 papers have used this inhibitor, confirming its specificity in vitro. Results of ex vivo tissue explant experiments have implicated the involvement of MEKs in a wide range of developmental processes including angiogenesis [19,20], renal tubulogenesis [21,22], somitic segmentation [23], lens differentiation [24] as well as guidance and segregation of retinal afferents during mammalian visual system development [25,26]. In vivo testing of U0126 has been carried out in ascidian species (Halocynthia roretzi and Ciona intestinalis), where U0126 treatment blocked differentiation of mesenchyme, secondary muscle and neural tissues and formation of the notochord (NC) [27-29].
###end p 10
###begin p 11
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
The NC serves as the most important skeletal structure in lower chordates and plays an essential role in vertebral column development in vertebrates. Its equally important function is to provide critical signaling molecules to neighbouring tissues (eg. neurectoderm, paraxial mesoderm), directing their differentiation [30]. The mature NC develops from the chordamesoderm, a derivative of dorsal mesoderm, and is ultimately incorporated into the forming vertebrae as the nucleus pulposus.
###end p 11
###begin p 12
###xml 31 40 <span type="species:ncbi:7955">zebrafish</span>
Here we report the analysis of zebrafish embryos treated with the MEK1/2 inhibitor U0126 which causes an almost 100% penetrant, dose-dependent and reproducible phenotype consisting of short trunk and tail, lack of dark pigmentation, and abnormal NC development. Time-course and washout experiments revealed that the treatment has to be applied within a strict time window from the beginning of gastrulation until 16-18-somite stage (around 18 hours post-fertilization, hpf) and the strength of the phenotype correlates with the level of Erk phosphorylation observed in the embryos. The NCs of U0126 treated embryos develop undulations and form multi cell-layer lumps instead of the single "stack-of-coins" structure observed in wild type siblings. Electron microscopy revealed defects in the multilayered structure of the perinotochordal basement membrane (PNBM) which supports NC cells against their own high internal hydrostatic pressure. We show that the shorter tail of the treated embryos is due to an increase in apoptosis and not to a decrease in number of mitotic cells. Gene expression analysis showed that U0126 affects the chordamesoderm to mature NC transition step. Surprisingly, ventral fates in the neural tube are not affected while development of the dorsal aorta and intersomitic vessels is severely disturbed. U0126-treated embryos do not show any significant similarity to those treated with the FGF-signaling inhibitor SU5402 which suggests that an alternative pathway is required to activate MEK during NC development. We also examined possible links to pathways whose inhibition in different mutants produce a very similar phenotype including COPI-mediated intracellular transport and the copper-transporter Atp7a. We conclude that MEK1/2 inhibition did not decrease the expression of any of the potential genes examined, nevertheless, interactions between these processes and MAPK1/2 signaling may exist at the protein level.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 81 90 <span type="species:ncbi:7955">zebrafish</span>
U0126 treatment during gastrulation causes notochord and pigmentation defects in zebrafish
###end title 14
###begin p 15
###xml 97 106 97 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 115 123 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 367 372 367 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/A,B</xref>
###xml 633 636 633 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/C</xref>
###xml 680 689 680 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 853 862 851 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 863 864 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1090 1093 1087 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/D</xref>
###xml 154 163 <span type="species:ncbi:7955">zebrafish</span>
###xml 215 224 <span type="species:ncbi:7955">zebrafish</span>
The specificity of U0126 as a MEK1/2 inhibitor has already been established by many studies both in vitro [31] and in vivo [32] including one analysis in zebrafish [33]. Consistent with those analyses, treatment of zebrafish embryos with U0126 from early gastrulation led to complete abrogation of the phosphorylation of Erk1/2, the downstream target of Mek1/2 (Fig. 1/A,B). This was not the case when the embryos were treated under the same the same conditions with U0124, a small molecule with a slightly changed composition which results in loss of MEK1/2 inhibitory capacity, supporting the specificity of the U0126 effect (Fig. 1/C). PD98059, also used as a MEK1/2 inhibitor in vitro [34], caused no phenotype whatsoever at 20 muM and resulted in 100% lethality at 30 muM concentration. PD98059 has been shown to be 100-fold less potent than U0126 in vitro [9]. This suggests that its lethality at such a low concentration was due to non-specific causes, preventing us from analysing its effect as a MEK1/2 inhibitor. Indeed, embryos treated with sublethal 20 and 25 muM PD98059 (Fig. 1/D; panel is 25 muM) had normal phospho-ERK1/2 staining, suggesting normal MEK activity.
###end p 15
###begin p 16
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U0126 application during a specific time-window decreases ERK phosphorylation specifically</bold>
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 152 153 152 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 418 419 418 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 466 467 466 467 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 577 578 576 577 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 683 684 682 683 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 794 795 793 794 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 962 963 961 962 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 235 244 <span type="species:ncbi:7955">zebrafish</span>
U0126 application during a specific time-window decreases ERK phosphorylation specifically. A: Diphospho-Erk staining in the trunk of wt 24 hpf embryos.B: U0126 eliminates ERK1/2 phosphorylation (green) in the trunk and tail of 24 hpf zebrafish embryos. Notice that U0126-treated embryos have been overexposed (can be judged by the autofluorescence of the yolk sac extension) and still fail to show specific staining. C: U0124 does not eliminate the p-Erk staining. D: PD98059 also does not eliminate p-Erk staining when given just below the level of lethal toxicity (25 muM). E: Somewhat weaker but still significant p-Erk staining in embryos treated with U0126 starting at 10 hpf. F: Western-blot analysis demonstrated a slight but incomplete reduction in pErk1/2 levels in 10-somite embryos.G: Stage and dose-dependency of U0126 application. There is a dramatic drop in the percentage of affected embryos when treatment is applied after epiboly is completed. H: Washout experiments reveal the necessity of U0126 to be present until at least the 18 somite stage to produce the full phenotype.
###end p 16
###begin p 17
###xml 97 100 97 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/G</xref>
###xml 661 664 660 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/G</xref>
###xml 967 970 965 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/E</xref>
###xml 1187 1190 1185 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/G</xref>
Next we tested the inhibitor at several concentrations and at several starting time-points (Fig. 1/G). The lowest effective concentration that still gave the strongest observed phenotype (detailed below) was 100 muM, so that was used in all subsequent experiments. Higher concentrations of the inhibitor (up to 1 mM; U0126 precipitates beyond 1 mM) did not produce a stronger or different effect, suggesting low non-specific toxicity of U0126. The induced phenotype was very distinct and reproducible, while DMSO sham controls never showed any defects. In order to achieve maximum effect, it was necessary to apply the inhibitor during early gastrulation (Fig. 1/G). Under these conditions (100 muM applied at early gastrulation), the efficacy rate of the experiments never fell below 90% in several thousand embryos. When the drug was added at later stages (starting 85-90% epiboly or afterwards) the effect on Erk1/2 phosphorylation was proportionally weaker (Fig. 1/E), appeared later and affected only the posterior part of the NC. Treatment with lower concentrations of U0126 from early gastrulation also produced a weaker phenotype and reduced the number of affected embryos (Fig. 1/G).
###end p 17
###begin p 18
###xml 579 582 579 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/F</xref>
###xml 693 702 <span type="species:ncbi:7955">zebrafish</span>
To examine whether slow penetration of U0126 into the embryo might explain why there is such a delay between treatment and derived effect we stained embryos at 10 somite stage with pERK1/2 (as above). As suspected, there was no decrease in pErk1/2 signal (data not shown) suggesting that the drug did not penetrate quickly. To examine this with greater sensitivity we carried out Western-blot analysis using the pERK1/2 antibody on lysates of the U0126 treated and DMSO control embryos at the same 10 somite stage. This revealed a decrease in pErk1/2 after U0126 treatment (Fig. 1/F). Nevertheless, there was still some pErk1/2 present indicating slow penetration and/or effect of the drug in zebrafish embryos.
###end p 18
###begin p 19
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/H</xref>
###xml 482 485 482 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1/G</xref>
To identify the time point when U0126 has to be present to induce the NC phenotype, we also carried out washout experiments at different stages of development. These demonstrated that U0126 has to be continously present from the onset of gastrulation until at least 17-18 somite stage to achieve full penetrance of the phenotype (Fig. 1/H). When washed out earlier than that, only the anterior part of the NC was affected. This result, combined with the late application data (Fig. 1/G) suggests the existence of a time-window during which the NC cells are sensitive to U0126. This sensitivity window moves in an A-P direction as the NC differentiates. For subsequent experiments we routinely started treating the embryos at the onset of gastrulation and kept them in the inhibitor until the required fixation time-point.
###end p 19
###begin p 20
###xml 250 255 250 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2/G&#8211;I</xref>
###xml 266 271 266 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2/J&#8211;L</xref>
###xml 767 776 767 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
U0126 incubation produced a phenotype with two major characteristics. First, the embryos lacked all accumulations of the dark pigment melanin and remained completely translucent provided that they were kept continuosly in the inhibitor (Compare Fig. 2/G-I with Fig. 2/J-L). If taken out from the U0126 solution after 24 hpf, dark pigmentation slowly recovered although it never became quite as strong as it was in control embryos. Following this recovery, the pattern of pigmentation was identical to the untreated controls', albeit not as strong. A likely explanation for the pigmentation effect of U0126 was provided recently by Gelfand and colleagues who showed that U0126 treatment inhibits melanosome transportation within fully differentiated melanophore cells in vitro [35].
###end p 20
###begin p 21
###xml 0 99 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U0126 produces a specific and consistent phenotype affecting pigmentation and notochord development</bold>
###xml 162 165 162 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-F</bold>
###xml 182 185 182 185 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-L</bold>
###xml 274 276 274 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I </bold>
###xml 280 281 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 349 350 349 350 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 352 353 352 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 436 438 436 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G </bold>
###xml 442 443 442 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 598 601 598 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 603 606 603 606 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-I</bold>
###xml 634 637 634 637 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-F</bold>
###xml 639 642 639 642 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J-L</bold>
U0126 produces a specific and consistent phenotype affecting pigmentation and notochord development. Phenotype of wild type and U0126-treated embryos at 24 hpf. (A-F) and at 48 hpf (G-L). There is a total lack of pigmentation including in the RPE in the eye (compare panels I and L), twists and undulations in the NC are already evident at 24 hpf. (D, E) and the trunk and tail of treated embryos is shortened at 48 hpf (compare panels G and J). The large yolk sac in 48 hpf embryos indicates that circulation is not established properly to carry away its content (see also later in Fig. 5) Panels A-C, G-I: wild type embryos. Panels D-F, J-L: U0126-treated embryos.
###end p 21
###begin p 22
###xml 254 263 254 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2/A,B,D,E</xref>
###xml 361 366 361 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2/C,F</xref>
###xml 428 433 428 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2/G,J</xref>
###xml 524 530 524 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3./E,F</xref>
###xml 642 647 642 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2/H,K</xref>
###xml 719 724 719 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2/I,L</xref>
The second major defect consisted of severe morphological abnormalities in the trunk of U0126 treated embryos. The first sign of this was a ventral bending of the tail of treated embryos at around 20 hpf. By 24 hpf the the NC was severely affected (Fig. 2/A,B,D,E), while other parts of the treated embryo (brain, somites) appeared morphologically normal (Fig. 2/C,F). By 48 hpf the tail was significantly shorter (compare Fig. 2/G,J), the somites had a straight shape instead of the normal chevron (V) shape (see also Fig. 3./E,F), and the NC developed very severe kinks, thickenings and undulations, sometimes even knot-like features (Fig. 2/H,K). At this stage the structure of the brain still appeared normal (Fig. 2/I,L), but soon afterwards a necrotic process was initiated here which spread over the embryo resulting in death during the following couple of days.
###end p 22
###begin p 23
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Early processes are not affected by U0126 with the exception of apoptosis</bold>
###xml 75 78 75 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-D</bold>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsc </italic>
###xml 114 115 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 117 118 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eve1 </italic>
###xml 167 168 167 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 170 171 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 403 404 403 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 406 407 406 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 597 598 593 594 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 600 601 596 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 632 640 628 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pax 2.1 </italic>
###xml 688 693 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myoD </italic>
###xml 872 876 868 872 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I-L:</bold>
###xml 876 879 872 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh</italic>
###xml 887 891 883 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdx1</italic>
###xml 893 896 889 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O.P</bold>
###xml 898 902 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eve1</italic>
###xml 904 905 900 901 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Q</bold>
###xml 907 908 903 904 <bold xmlns:xlink="http://www.w3.org/1999/xlink">R</bold>
###xml 910 914 906 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8</italic>
###xml 916 917 912 913 <bold xmlns:xlink="http://www.w3.org/1999/xlink">S</bold>
###xml 919 920 915 916 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 934 942 930 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh-GFP </italic>
###xml 1040 1043 1032 1035 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U-X</bold>
###xml 1084 1085 1076 1077 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U</bold>
###xml 1087 1088 1079 1080 <bold xmlns:xlink="http://www.w3.org/1999/xlink">V</bold>
###xml 1102 1103 1094 1095 <bold xmlns:xlink="http://www.w3.org/1999/xlink">W</bold>
###xml 1105 1106 1097 1098 <bold xmlns:xlink="http://www.w3.org/1999/xlink">X</bold>
###xml 1153 1155 1145 1147 <bold xmlns:xlink="http://www.w3.org/1999/xlink">X </bold>
###xml 1210 1219 1202 1211 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 6/F </bold>
###xml 1247 1249 1239 1241 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Y'</bold>
###xml 1731 1732 1723 1724 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1734 1735 1726 1727 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1737 1738 1729 1730 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1740 1741 1732 1733 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1743 1744 1735 1736 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1746 1747 1738 1739 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 1749 1750 1741 1742 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 1752 1753 1744 1745 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O</bold>
###xml 1755 1756 1747 1748 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Q</bold>
###xml 1758 1759 1750 1751 <bold xmlns:xlink="http://www.w3.org/1999/xlink">S</bold>
###xml 1761 1762 1753 1754 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U</bold>
###xml 1764 1765 1756 1757 <bold xmlns:xlink="http://www.w3.org/1999/xlink">W</bold>
###xml 1793 1794 1785 1786 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1796 1797 1788 1789 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1799 1800 1791 1792 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 1802 1803 1794 1795 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 1805 1806 1797 1798 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 1808 1809 1800 1801 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 1811 1812 1803 1804 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 1814 1815 1806 1807 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P</bold>
###xml 1817 1818 1809 1810 <bold xmlns:xlink="http://www.w3.org/1999/xlink">R</bold>
###xml 1820 1821 1812 1813 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 1823 1824 1815 1816 <bold xmlns:xlink="http://www.w3.org/1999/xlink">V</bold>
###xml 1826 1827 1818 1819 <bold xmlns:xlink="http://www.w3.org/1999/xlink">X</bold>
###xml 1859 1860 1851 1852 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1862 1864 1854 1856 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
Early processes are not affected by U0126 with the exception of apoptosis. A-D: Expression the dorsal marker gsc (A, B,), and the ventral mesodermal marker gene eve1 (D, E) is not changed in 7 hpf. U0126-treated animals. As treated and wt animals could not be separated at this stage, a large number of embryos were treated and some of them were raised till 24 hpf. to make sure the drug was effective. E, F: Narrower, straighter somites in U0126-treated embryos as demonstrated by the reduced distance between the motoneurons (1 motoneuron/somite) stained with alpha-Acetylated-Tubulin antibody. G, H: Lateral mesoderm marker gene pax 2.1 (purple) and the somitic mesodermal marker gene myoD (red) do not show altered expression in dorsal view of flat-mounted 9-somite stage embryos. Expression of genes involved in tail development is not changed after U0126-treatment. I-L:flh. M, N: cdx1. O.P: eve1. Q, R: fgf8. S, T: Examples of shh-GFP and alpha-phosphorylated Histone3 double antibody staining used to count mitotic cells in the NC. U-X: Examples of TUNEL stainings of 24 hpf (U, V) and 48 hpf (W, X) wt and U0126-treated embryos (inset in panel X shows larger magnification and see these cells also in Fig. 6/F marked with yellow arrows). Y': The average numbers of phosphorylated Histone3 (pH3) positive cells in the anterior and posterior trunk and tail do not differ between wt and U0126-treated embryos. Average numbers of TUNEL positive cells in whole embryos (Y") and notochord-only (Y"') at 20 somites and 24 hpf demonstrate a significant increase in U0126-treated embryos at 24 hpf (p = 0.0087 unpaired t-test with welch's correction, 24 hpf values). Note that there is no change in apoptosis within the NC. Panels A, C, E, G, I, K, M, O, Q, S, U, W: wild type embryos. Panels B, D, F, H, J, L, N, P, R, T, V, X: U0126-treated embryos. Panels A, D animal pole view, dorsal to the right.
###end p 23
###begin title 24
U0126 does not affect early dorso-ventral patterning and convergent-extension movements during gastrulation
###end title 24
###begin p 25
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 495 544 495 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">swirl, somitabun, lost-a-fin, minifin, snailhouse</italic>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gsc </italic>
###xml 803 807 803 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eve1</italic>
###xml 884 889 884 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/A&#8211;D</xref>
###xml 335 344 <span type="species:ncbi:7955">zebrafish</span>
###xml 472 481 <span type="species:ncbi:7955">zebrafish</span>
The previous experiments revealed that in order to achieve the maximum NC phenotype, inhibitor treatment must commence at the start of gastrulation, so we examined whether patterning processes occuring at this time are affected by U0126. FGF signaling, which transduces its signal through the MAPK pathway, plays a significant role in zebrafish dorso-ventral (D-V) and anterior-posterior (A-P) patterning and tail formation [36-39]. Moreover, embryos of mildly dorsalized zebrafish mutants (eg. swirl, somitabun, lost-a-fin, minifin, snailhouse; [40,41]) have a shift in mesendodermal fate, producing more notochordal tissue and less, or no, ventral mesoderm which could be the reason for the undulating NC found in U0126-treated embryos. To examine this possibility, we checked distribution of gsc and eve1, a dorsal and ventral mesoderm marker, respectively. Neither of these (Fig. 3/A-D), nor similar markers examined (data not shown) had an altered expression pattern, indicating that D-V specification is not disturbed by U0126 treatment.
###end p 25
###begin p 26
###xml 211 216 211 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/E,F</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 250 257 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">knypek </italic>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myoD </italic>
###xml 515 522 515 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pax2.1 </italic>
###xml 601 606 601 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/G,H</xref>
###xml 269 278 <span type="species:ncbi:7955">zebrafish</span>
###xml 292 302 <span type="species:ncbi:7227">Drosophila</span>
Another process that may be affected by U0126 treatment is convergent-extension (C-E). C-E defects produce a short trunk and compressed, straight somites similar to those observed in U0126-treated embryos (Fig. 3/E,F) [42,43]. Moreover, a C-E mutant knypek encodes the zebrafish homologue of Drosophila glypican: a heparan-sulfate proteoglycan mediator of FGF signaling [44]. However, 8-somite stage U0126-treated embryos showed no defects in the expression of somitic and lateral mesodermal marker genes (myoD and pax2.1 respectively), indicating no delays in C-E movements of mesodermal cells (Fig. 3/G,H).
###end p 26
###begin p 27
###xml 214 230 214 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flh, fgf8, eve1 </italic>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdx1 </italic>
###xml 244 249 244 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/I&#8211;R</xref>
Alternatively, the short tail phenotype could also be the result of a defect in tail elongation. However, no change was observed in the expression of a number of genes known to be involved in this process, such as flh, fgf8, eve1 or cdx1 (Fig. 3/I-R).
###end p 27
###begin p 28
###xml 411 419 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh-GFP </italic>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 509 517 509 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/S,T,Y'</xref>
###xml 611 618 611 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/Y'</xref>
###xml 1529 1533 1525 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/Y"</xref>
###xml 1633 1641 1629 1637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/U&#8211;V,Y"</xref>
###xml 1933 1938 1929 1934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/Y"'</xref>
###xml 2022 2025 2018 2021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3/X</xref>
###xml 2056 2059 2052 2055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/F</xref>
We next checked whether an increase in cell division in the NC could be responsible for the generation of undulations in this stucture. To follow changes in mitosis, we counted dividing cells in the NC of wild type and treated embryos stained for the mitotic marker phospho-histone3 (which labels cells that are in the M phase at the time of fixation). To ensure that we only counted notochordal cells, we used shh-GFP embryos [45] as a counterstain and only double stained cells were counted (arrows in Fig. 3/S,T,Y'). This revealed no differences in the number of M phase cells in the NC at 24 hpf in control versus U0126-treated embryos (Fig. 3/Y'; wt: 37 alpha-H3 positive NC cells/7 embryos; U0126-treated: 35 positive NC cells/7 embryos). To assess any changes in the A-P distribution of mitoses, cells between the posterior tip of the tail and the end of the yolk tube extension were also counted separately. The distribution of mitotic cells also did not change in treated embryos (11 cells/7 embryos in both cases). Thus, changes in cell division rates in the NC are unlikely to be responsible for its undulations. U0126 treatments did, however, increase apoptosis in the tail of treated embryos, as assessed by TUNEL staining. Since the number of TUNEL positive cells showed substantial variability (between 20 and 150 cells/embryo), we carried out counting on a large number of embryos (24 embryos/sample). At 20 hpf there was no difference in the number of apoptotic cells between wild type and treated embryos (Fig. 3/Y"), but by 24 hpf there was a specific and severe increase of apoptosis in the tail mesenchyme (Fig. 3/U-V,Y") of about one-third of the treated embryos. The increased apoptosis in the tail mesenchyme could explain the shortness of 48 hpf embryos, and may account, at least partially, for the undulations of the NC. On the other hand, we could not detect any increase in apoptosis within the NC (Fig. 3/Y"'). At 48 hpf apoptosis was also initiated in the smaller, vacuolated NC cells (Fig. 3/X, inset; yellow arrows in Fig. 6/F). Apoptosis in the NC remained restricted to these cells.
###end p 28
###begin title 29
U0126 treatment disrupts the chordamesoderm to mature notochord transition and proper signaling to surrounding tissues
###end title 29
###begin p 30
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 612 617 612 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4/A&#8211;D</xref>
###xml 759 764 759 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4/E&#8211;H</xref>
###xml 927 931 927 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ehh </italic>
###xml 935 939 935 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh </italic>
###xml 948 952 948 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twhh</italic>
###xml 1020 1031 1020 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">col2&#945;1 </italic>
###xml 1058 1064 1054 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsp47 </italic>
###xml 1070 1075 1066 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4/I&#8211;P</xref>
###xml 1194 1204 1190 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fkd1, fkd4</italic>
###xml 1211 1220 1207 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4/Q,R,U,V</xref>
###xml 1233 1255 1229 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tiggy-winkle hedgehog </italic>
###xml 1256 1260 1252 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twhh</italic>
###xml 1267 1272 1263 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/I,J</xref>
###xml 1275 1284 1271 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spondin2 </italic>
###xml 1288 1294 1284 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mindin</italic>
###xml 1355 1360 1351 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4/Q&#8211;X</xref>
###xml 258 267 <span type="species:ncbi:7955">zebrafish</span>
###xml 282 287 <span type="species:ncbi:10090">mouse</span>
###xml 588 597 <span type="species:ncbi:7955">zebrafish</span>
To find the possible molecular consequences of U0126 treatment which led to the NC phenotype, we inspected the expression pattern of structural and regulatory genes involved in NC differentiation, most of which also play a role in tail development. ntl, the zebrafish orthologue of mouse Brachyury, is involved in NC and tail development in all vertebrates examined so far [46-50]. In wild type embryos, ntl is expressed in the NC during its development and from 20 hpf its expression progressively decays in an A-P fashion. Early expression of ntl was absolutely normal in U0126-treated zebrafish embryos (Fig. 4/A-D). From 20 hpf onwards however, unlike in untreated siblings, its expression did not decrease, in fact it was maintained at high levels (Fig. 4/E-H). This lack of proper mRNA decay in treated embryos also characterized expression of several other genes important in NC development and tail formation including ehh and shh (but not twhh) from the Hh family of signaling molecules, the structural protein col2alpha1 and its specific chaperone hsp47 (Fig. 4/I-P). In contrast, other genes also involved in NC development, such as members of type I forkhead transcription factors (fkd1, fkd4; Fig. 4/Q,R,U,V) as well as tiggy-winkle hedgehog (twhh; Fig. 5/I,J), spondin2 and mindin, showed normal expression dynamics in treated embryos (Fig. 4/Q-X).
###end p 30
###begin p 31
###xml 0 130 0 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genes important in notochord differentiation exhibit two types of regulatory pattern during chordamesoderm to mature NC transition</bold>
###xml 132 135 132 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-H</bold>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 194 197 194 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-D</bold>
###xml 305 308 305 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E-H</bold>
###xml 312 313 312 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 315 316 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 325 326 325 326 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 328 329 328 329 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 339 343 339 343 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E-H </bold>
###xml 399 403 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ehh </italic>
###xml 404 405 404 405 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 407 408 407 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 411 415 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh </italic>
###xml 416 417 416 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 419 420 419 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 423 434 423 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">col2&#945;1 </italic>
###xml 435 436 431 432 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 438 439 434 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 445 451 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsp47 </italic>
###xml 452 453 448 449 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O</bold>
###xml 455 456 451 452 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P</bold>
###xml 470 473 466 469 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Q-X</bold>
###xml 490 495 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fkd1 </italic>
###xml 496 497 492 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Q</bold>
###xml 499 500 495 496 <bold xmlns:xlink="http://www.w3.org/1999/xlink">R</bold>
###xml 503 508 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fkd4 </italic>
###xml 509 510 505 506 <bold xmlns:xlink="http://www.w3.org/1999/xlink">S</bold>
###xml 512 513 508 509 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 516 525 512 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spondin2 </italic>
###xml 526 527 522 523 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U</bold>
###xml 529 530 525 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink">V</bold>
###xml 536 543 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mindin </italic>
###xml 544 545 540 541 <bold xmlns:xlink="http://www.w3.org/1999/xlink">W</bold>
###xml 547 548 543 544 <bold xmlns:xlink="http://www.w3.org/1999/xlink">X</bold>
###xml 690 693 686 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M-X</bold>
###xml 717 718 713 714 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O</bold>
###xml 720 721 716 717 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P</bold>
###xml 723 726 719 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U-X</bold>
###xml 762 763 758 759 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 765 766 761 762 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 768 769 764 765 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 771 772 767 768 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 774 775 770 771 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 777 778 773 774 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 780 781 776 777 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 783 784 779 780 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O</bold>
###xml 786 787 782 783 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Q</bold>
###xml 789 790 785 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink">S</bold>
###xml 792 793 788 789 <bold xmlns:xlink="http://www.w3.org/1999/xlink">U</bold>
###xml 795 796 791 792 <bold xmlns:xlink="http://www.w3.org/1999/xlink">W</bold>
###xml 817 818 813 814 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 820 821 816 817 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 823 824 819 820 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 826 827 822 823 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 829 830 825 826 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 832 833 828 829 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 835 836 831 832 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 838 839 834 835 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P</bold>
###xml 841 842 837 838 <bold xmlns:xlink="http://www.w3.org/1999/xlink">R</bold>
###xml 844 845 840 841 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T</bold>
###xml 847 848 843 844 <bold xmlns:xlink="http://www.w3.org/1999/xlink">V</bold>
###xml 850 851 846 847 <bold xmlns:xlink="http://www.w3.org/1999/xlink">X</bold>
Genes important in notochord differentiation exhibit two types of regulatory pattern during chordamesoderm to mature NC transition. A-H: Expression of ntl is normal during early NC development (A-D) in treated embryos but fails to get downregulated during the chordamesoderm to mature NC transition step (E-H). (A, B: 7 hpf; C, D: 12 hpf; E-H 24 hpf.) This pattern of developmental arrest occurs in ehh (I, J), shh (L, K), col2alpha1 (M, N) and hsp47 (O, P) expression. Q-X: mRNA levels of fkd1 (Q, R), fkd4 (S, T), spondin2 (U, V) and mindin (W, X) however decreases normally upon chordamesoderm to mature NC transition. Notice the unchanged expression of marker genes in the floor plate (M-X) and in the hypochord (O, P, U-X) of U0126-treated embryos. Panels: A, C, E, G, I, K, M, O, Q, S, U, W: wild type. Panels: B, D, F, H, J, L, N, P, R, T, V, X: U0126-treated embryos.
###end p 31
###begin p 32
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Not all tissues receiving notochord-emitted signals are affected by U0126 treatment</bold>
###xml 85 88 85 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-D</bold>
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flk-1 </italic>
###xml 343 344 343 344 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 401 406 401 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myoD </italic>
###xml 436 437 436 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 439 440 439 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eng2 </italic>
###xml 498 499 498 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 501 502 501 502 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 565 566 565 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 568 570 568 570 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J </bold>
###xml 579 589 579 589 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 4/M&#8211;X</bold>
###xml 592 598 592 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Isl-1 </italic>
###xml 710 711 710 711 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 713 714 713 714 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
Not all tissues receiving notochord-emitted signals are affected by U0126 treatment. A-D: flk-1 expression reveals defects in dorsal aorta differentiation (green arrow in panel D) and in the sprouting of intersomitic vessels. Notice that both lack of sprouting (yellow arrows) and double sprouting (red arrow) occurs in U0126-treated embryos (D). Expression of the early muscle differentiation marker myoD is normal in treated embryos (E, F) but the muscle pioneer cell marker eng2 is upregulated (G, H). The floor plate of the neural tube differentiates normally (I, J and also Fig. 4/M-X). Isl-1 expression shows that the sensory Rohon-Beard neurons and motoneurons both develop properly in treated embryos (K, L)
###end p 32
###begin p 33
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flk </italic>
###xml 305 311 305 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tie-2 </italic>
###xml 334 344 334 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fli1-eGFP </italic>
###xml 435 440 435 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/A&#8211;D</xref>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">flk </italic>
###xml 534 537 534 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/D</xref>
###xml 642 645 642 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/D</xref>
###xml 816 819 816 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/D</xref>
Since expression of many genes belonging to developmentally important signaling pathways were affected by U0126-treatment, we examined whether differentiation of surrounding tissues known to require NC-emitted signals for their development (muscle, neural tube, circulatory system) were affected. flk and tie-2 expression, as well as Fli1-eGFP fluorescence all revealed considerable defects in circulatory system differentiation (Fig. 5/A-D; data not shown). Disruptions of flk gene expression were observed in the dorsal aorta (Fig. 5/D), and we also detected double sprouting of intersomitic vessel progenitors within the same somite (Fig. 5/D, red arrow). In most cases, however, there was no detectable sprouting at all from the precursors, suggesting that development of these vessels requires NC signals (Fig. 5/D, yellow arrows).
###end p 33
###begin p 34
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myoD </italic>
###xml 88 93 88 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/E,F</xref>
###xml 142 154 138 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropomyosin </italic>
###xml 259 263 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eng2</italic>
###xml 429 434 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eng2 </italic>
###xml 563 568 559 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/G,H</xref>
Early muscle differentiation markers showed only very mild or no defects (eg. myoD Fig. 5/E,F). Also, expression of the sarcomeric gene alpha-tropomyosin was not affected at all (data not shown). The level of expression of the slow muscle pioneer cell marker eng2, however, was significantly increased. Instead of its normal staining pattern, where only the anteriormost 2-3 cells in each somite at the somitic midline expresses eng2 mRNA, in U0126-treated embryos its expression spanned the entire myotome producing a continuous band along the D-V midline (Fig. 5/G,H).
###end p 34
###begin p 35
###xml 293 298 293 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/A&#8211;D</xref>
###xml 332 377 332 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh, twhh, col2&#945;1, fkd1, fkd,4, spondin2 </italic>
###xml 381 388 377 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mindin </italic>
###xml 400 405 396 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/I,J</xref>
###xml 415 424 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4/M,N,Q&#8211;X</xref>
###xml 467 473 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">isl-1 </italic>
###xml 573 578 569 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5/K,L</xref>
The neural tube lies just dorsal to the NC and proper differentiation of its ventral part (floor plate, motoneurons) is dependent on notochordal signals. Despite this, and much to our surprise, the floor plate developed normally in U0126-treated embryos as judged both by its morphology (Fig. 6/A-D) and by the normal expression of shh, twhh, col2alpha1, fkd1, fkd,4, spondin2 and mindin genes (Fig. 5/I,J and Fig. 4/M,N,Q-X). Moreover, ventral motoneurons marked by isl-1 also differentiated properly (both in numbers as well as in position) from neural progenitors (Fig. 5/K,L).
###end p 35
###begin p 36
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Defects in the cellular organization of the notochord and PNBM structure of U0126-treated embryos</bold>
###xml 259 260 259 260 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 494 495 494 495 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 497 498 497 498 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 645 647 645 647 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F </bold>
###xml 663 671 663 671 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 3/X</bold>
###xml 841 843 841 843 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E </bold>
###xml 880 882 880 882 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H </bold>
###xml 1199 1200 1199 1200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1202 1203 1202 1203 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 1223 1224 1223 1224 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 1226 1227 1226 1227 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 1459 1460 1459 1460 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 1462 1463 1462 1463 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 1473 1474 1473 1474 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1476 1477 1476 1477 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1479 1480 1479 1480 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1482 1483 1482 1483 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1485 1486 1485 1486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1488 1489 1488 1489 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 1517 1518 1517 1518 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 1520 1521 1520 1521 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1523 1524 1523 1524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 1526 1527 1526 1527 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 1529 1530 1529 1530 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 1532 1533 1532 1533 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
Defects in the cellular organization of the notochord and PNBM structure of U0126-treated embryos. In 24 hpf. U0126-treated embryos notochordal cells adhere to the sheath at preferential focal points which results in the bending of the NC (red arrow in panel B). Phalloidin stainings reveal smaller amount of fibrillar actin present between NC cells but not in the overlying neural tube. Notice the large vacuolar cells and the periferial positioning of nuclei in U0126-treated embryos (panels C, D). By 48 hpf. the NC of U0126-treated embryos with milder phenotypes contains smaller rounded cells which become apoptotic (yellow arrows in panel F and see also in Fig. 3/X). Embryos with stronger phenotypes have large bulges protruding where the flat sheath cells surrounding the large vacuolated cells are missing (see blue arrows in panel E for normal sheath cells and in panel H marking the last sheath cells surrounding the bulge; red arrows mark the region devoid of sheath cells). Laminin expression and ultrastructure of the inner layer of the PNBM (marked with blue arrowheads) composed mainly of laminins are normal in NC treated embryos as demonstrated by whole-mount immunhistochemistry (I, J) and TEM pictures (K, L). The middle (green bracket) and outer (yellow bracket) layers of the PNBM composed mainly of circumferential and longitudinal collagen fibers respectively show decreased length and/or disorganization in the orientation of fibers (K, L). Panels A, C, E, G, I, K: wild type embryos. Panels B, D, F, H, J, L: U0126-treated embryos.
###end p 36
###begin title 37
U0126 treatment induces changes in the actin based cytoskeleton and in the structure of the perinotochordal basement membrane
###end title 37
###begin p 38
###xml 307 310 307 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/A</xref>
###xml 764 767 764 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/B</xref>
###xml 1222 1227 1222 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/C,D</xref>
To investigate the NC morphology of treated embryos in more detail, we used the lipophilic vital dye Bodipy ceramide, which remains extracellular and outlines the borders of living cells. Staining of 24 hpf control embryos revealed a single row of cells in the NC arranged in a "stack-of-coins" shape (Fig. 6/A). At this age approximately every fourth or fifth cell already showed signs of vacuolation, which is the first visible morphological change in the chordamesoderm to NC differentiation process. In wild type embryos the NC cells were also still attached to the PNBM very evenly. In the NC of U0126-treated embryos this even distribution of cells was broken at several places, with 4-5 NC cells adhering to the PNBM at the same spot (See red arrow in Fig. 6/B). Such focused adhesion probably creates mechanical tension causing the NC to bend towards the adhesion point and might become an initiator during subsequent kinking/bending of the NC. The appearance of these structures suggested that there might be cell adhesion or/and cytoskeletal defects involved in the generation of the phenotype, so we next examined the distribution of fibrillar actin (F-actin) via fluorescent phalloidin staining (green in Fig. 6/C,D), with the nuclei being counterstained by Sytox dye (red).
###end p 38
###begin p 39
###xml 167 170 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/D</xref>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/D</xref>
###xml 575 578 575 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/D</xref>
In the medial part of the NC of U0126-treated embryos the phalloidin staining appeared significantly weaker indicating that a lower level of F-actin was present (Fig. 6/D). There was also a change in the appearance and rearrangement of notochordal cells with smaller cuboidal cells lying ventrally along the NC sheath (Fig. 6/D, blue arrows). Due to this, the large vacuolated cells were not connected to the sheath directly on the ventral side. At the points of NC breaks (or severe bends) these smaller cells intruded into medial parts of the NC (see yellow arrows in Fig. 6/D).
###end p 39
###begin p 40
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/E</xref>
###xml 220 223 220 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/E</xref>
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/F</xref>
###xml 620 625 620 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/G,H</xref>
###xml 882 885 882 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/H</xref>
At 48 hpf the wild type NC contained large vacuolated cells with 2-3 similar size cells lying side by side (Fig. 6/E), and smaller flat epithelial-like sheath cells towards the edge, in close contact with the PNBM (Fig. 6/E, blue arrows). In U0126-treated embryos with a milder phenotype a large number of significantly smaller rounded cells with a vacuolated appearance were observed (Fig. 6/F, yellow arrows). It is not clear whether these cells are formed from the flat sheet cells secondarily or whether they are normal vacuolated cells that are simply smaller. In more severely affected U0126-treated embryos (Fig. 6/G,H), the flat sheath cells were not present continously along the NC and where they were missing, large bulges appeared in the NC consisting of large vacuolated cells (last sheath cells are marked with blue arrows on both sides of the bulge in the NC in Fig. 6/H). It is likely that the sheath cells, together with the PNBM, keep the normal shape of the NC by resisting the high internal hydrostatic pressure of vacuolated cells. The absence of the sheath cells in U0126 treated embryos may account for the formation of the large bulges in the NC.
###end p 40
###begin p 41
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 216 221 216 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/I&#8211;J</xref>
###xml 609 614 609 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/K,L</xref>
###xml 870 875 870 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6/K,L</xref>
###xml 36 45 <span type="species:ncbi:7955">zebrafish</span>
As the observed phenotype resembles zebrafish laminin mutants [51,52], we next checked the presence and distribution of laminin protein around the NC in U0126-treated embryos by whole-mount immunhistochemistry (Fig. 6/I-J.). Laminin is expressed normally in treated embryos, suggesting that U0126 affects events occuring downstream or in parallel with laminin in NC differentiation. This was also supported by ultrastructural evidence from transmission electron microscopic (TEM) sections which showed that in 48 hpf embryos the laminin-based inner layer of the PNBM was not affected by U0126 treatment (Fig. 6/K,L, blue arrowheads). The medial (green bracket) and outer layers (yellow bracket) composed mostly of longitudinally and perpendicularly oriented crosslinked collagen fibres (mainly type IV) however showed some disorganization in U0126-treated embryos (Fig. 6/K,L). This was particularly evident in areas where the profile of the NC was 'kinked'. In these regions of the sheath the inner layer of collagen filaments was thinner and contained shorter collagen fibrils. These 'shorter' fibrils may be truly shorter or may appear shorter in the ultrathin sections because their orientation is more longitudinal rather than circumferential to the NC. Either way, these observations suggest some disorganization in the collagen layers.
###end p 41
###begin p 42
In summary, we can conclude that most probably a combination of the lack of sheath cells and the disorganiation of the inner layer of the PNBM causes the multiple-cell wide bulgings in the NC of U0126-treated embryos. Although it is likely, at this point we can not yet conclude, whether there is a direct causal relationship between the missing sheath cells and the PNBM disorganization.
###end p 42
###begin title 43
U0126-treated embryos do not resemble FGF pathway-inhibited embryos
###end title 43
###begin p 44
###xml 330 338 330 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sef </italic>
###xml 541 546 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pea3 </italic>
###xml 550 558 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sprouty4</italic>
###xml 705 710 705 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7/A&#8211;C</xref>
###xml 747 754 747 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">col2a1 </italic>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh </italic>
###xml 856 861 856 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7/D&#8211;I</xref>
###xml 341 350 <span type="species:ncbi:7955">zebrafish</span>
As the FGF pathway is known to transmit its signals via the MAPK-Erk pathway and it is also involved in trunk and tail development, we examined whether U0126-treated embryos resemble those in which the FGF-pathway was abrogated. We used the FGF pathway inhibitor SU5402, which has previously been shown to inhibit the FGF pathway in vivo in zebrafish embryos [38,53]. However, phenotypes of embryos treated with SU5402 in the same time window as U0126lacked any similarity to U0126-treated embryos. Also, the Fgf-target gene sef (as well as pea3 and sprouty4; data not shown), which was downregulated in the somites and tail mesenchyme of SU5402-treated embryos, was not affected by U0126 treatment (Fig. 7/A-C). Moreover, the notochordal markers col2a1 and shh maintained a normal A-P pattern of expression decay in the NC of SU5402-treated embryos (Fig. 7/D-I). These data suggest that FGF-signaling is unlikely to be involved in the activation of MEK in the context of NC differentiation.
###end p 44
###begin p 45
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of the FGF pathway by SU5402 does not show any similarities to U0126-treated embryos</bold>
###xml 97 100 97 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-C</bold>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sef </italic>
###xml 176 177 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 205 206 205 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 217 220 217 220 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-I</bold>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">col2a1 </italic>
###xml 273 276 273 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-F</bold>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh </italic>
###xml 287 290 287 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G-I</bold>
###xml 357 360 357 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J-M</bold>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox1 </italic>
###xml 382 383 382 383 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 385 386 385 386 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox5b </italic>
###xml 399 402 399 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L-M</bold>
###xml 450 451 450 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 453 454 453 454 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O</bold>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">copa </italic>
Inhibition of the FGF pathway by SU5402 does not show any similarities to U0126-treated embryos. A-C: Expression of the Fgf-pathway target gene sef is downregulated in SU5402 (C) but not in U0126-treated (B) embryos. D-I: Expression of the notochordal marker genes col2a1 (D-F) and shh (G-I) also show different defects in SU5402 and U0126-treated embryos. J-M: Expression of lox1 (J, K) and lox5b (L-M) is not decreased normally by U0126-treatment. N, O: copa mRNA persists and is not downregulated by U0126-treatment.
###end p 45
###begin p 46
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 457 467 457 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox1, copa</italic>
###xml 536 545 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7/J,K,N,O</xref>
###xml 595 600 595 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7/L,M</xref>
###xml 96 105 <span type="species:ncbi:7955">zebrafish</span>
The disorganisation found in the NC sheath of U0126-treated embryos is also a characteristic of zebrafish mutants which affect COPI-mediated secretion processes [54] or those with inhibiton of proper copper metabolism via the copper-transporter Atp7ase [55]. Therefore we investigated whether expression of the available coatomer complex and copper-dependent lysyl-oxidase genes are changed in U0126-treated embryos. The mRNA levels of some of these genes (lox1, copa) were abnormally maintained at high levels in treated embryos (Fig. 7/J,K,N,O) or decayed normally in other cases (lox5a; Fig. 7/L,M) similarly to what was observed for other notochordal genes. This suggests that there is no direct regulation of these genes by the ERK pathway at the transcriptional level but it is still possible that such a regulatory interaction exists at the protein level. These studies will have to wait until specific antibodies are available for all phosphorylated and unphosphorylated COPI and lysyl-oxidase isoforms.
###end p 46
###begin title 47
Discussion
###end title 47
###begin title 48
###xml 58 67 <span type="species:ncbi:7955">zebrafish</span>
U0126 produces a specific effect during NC development in zebrafish
###end title 48
###begin p 49
As a welcome side-effect of large scale small molecule screens, developmental biologists now have access to specific inhibitors of various signaling pathways which could provide a simple solution for a temporally controllable inhibition of developmentally crucial pathways.
###end p 49
###begin p 50
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mek1-/- </italic>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 176 184 176 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mek2-/- </italic>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 359 368 <span type="species:ncbi:7955">zebrafish</span>
MEK1 and MEK2 underscore the usefulness of the chemical genetics approach. Mek1-/- mouse embryos die at E10.5 due to defective development of placental circulation [56], while Mek2-/- animals are viable, fertile and have no visible phenotype [57]. To reveal possible later and/or redundant functions of these kinases, we applied their inhibitor U0126 to live zebrafish embryos. Our results demonstrate a potential new role for the the MAPK pathway in NC differentiation.
###end p 50
###begin p 51
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 962 971 960 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 61 70 <span type="species:ncbi:7955">zebrafish</span>
###xml 182 191 <span type="species:ncbi:7955">zebrafish</span>
The specificity of U0126 has been previously demonstrated in zebrafish in vivo by Peterson and coworkers [33]. Here we show that U0126 effectively inhibits Erk1/2 phosphorylation in zebrafish embryos when applied from early gastrulation, and this correlates with the NC defect detected in our experiments. Treatment of embryos with U0124, a small molecule similar to U0126 but with a slightly changed composition, which results in loss of MEK1/2 inhibitory capacity, did not lead to NC defects. Accordingly, Erk1/2 phosphorylation was also unaffected by treatment with this drug. These results suggest that U0126 has a specific effect during NC differentiation. We tried a second inhibitor of MEK1/2, PD98059, which is 100-fold less potent than U0126. Unfortunately, PD98059 treatments were toxic to the embryos at 30 muM, and at sublethal concentrations (20-25muM) the embryos did not show any NC phenotype nor any decrease in Erk1/2 phosphorylation. Given the in vitro data and our results we have to conclude that the toxicity of this drug did not allow us to to compare its effect on NC development with that of U0126.
###end p 51
###begin title 52
U0126 disrupts the chordamesoderm to mature NC transition process
###end title 52
###begin p 53
###xml 330 336 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ci-Bra</italic>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ntl </italic>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 247 265 <span type="species:ncbi:7719">Ciona intestinalis</span>
###xml 365 374 <span type="species:ncbi:7955">zebrafish</span>
###xml 597 606 <span type="species:ncbi:7955">zebrafish</span>
Our data show that U0126 does not affect early patterning and morphogenetic events; rather it disrupts a later step during NC differentiation. This is in contrast to Ascidians where application of U0126 disrupts an early NC determination step. In Ciona intestinalis it also decreases expression of the early NC determination gene Ci-Bra, the ascidian orthologue of zebrafish ntl which as we demonstrated does not show any expression defects during early stages of NC differentiation [29,58]. This suggests that the U0126 target protein has an earlier function in Ascidian NC morphogenesis then in zebrafish. Alternatively, the drug may penetrate more rapidly into the significantly smaller Ascidian embryos.
###end p 53
###begin p 54
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1837 1845 1837 1845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shh-GFP </italic>
###xml 1917 1919 1917 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1920 1922 1920 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 3 12 <span type="species:ncbi:7955">zebrafish</span>
In zebrafish, at around 20 hpf chordamesoderm cells start to differentiate into mature NC and the mRNA levels of genes required for the early development and signaling function of the chordamesoderm are downregulated. Simultaneously, the cells of the differentiating NC begin to secrete the components of the PNBM, a structure which will support the NC against its own hydrostatic pressure and maintain its classic rod-like structure. Our expression analysis revealed that mRNA levels of important regulatory and structural genes are not downregulated in U0126-treated embryos indicating an arrest of NC differentiation at a stage which approximately corresponds to a 16 hpf embryo. Surprisingly, despite this, the surrounding tissues are only mildly (or not at all) affected with the exception of the developing circulatory system, which was analyzed in detail recently by Peterson and colleagues; [33], and the slow muscle pioneer cells, which are increased in number and expand in an A-P direction within the somitic midline The ventral neural tube (floor plate and the motoneurons, which also both require proper Hh-signaling from the NC however, differentiate properly. This mixed phenotype suggests that some tissues are not affected because the arrest in NC development happens only after it has already provided its essential signals to them (eg. to the neural tube), while others would still require proper signaling from the NC (eg. circulatory system, slow muscle pioneer cells). Alternatively, the difference is due to ability of the surrounding tissues to cope with the abnormal signals they recieve. Finally, it is possible that the NC cells are capable of handling the extra mRNA by translational or posttranslational regulatory mechanisms. This is supported by the fact that GFP protein levels in the NC of U0126-treated shh-GFP embryos appear to be downregulated normally by 48 hpf [data not shown; [45,59]].
###end p 54
###begin p 55
Even though the effects of the U0126 treatment are not visible until late in somitogenesis, our time-course and washout experiments revealed that the drug has to be applied from early gastrulation to achieve a fully penetrant phenotype. In addition, the chemical has to be kept on continously; when treatments start at later stages only the posterior part of the NC is affected and conversely, early washout of the chemical produces undulations only in the more anterior part of the NC. This suggests that there is a sensitivity window to MEK activity that moves from anterior to posterior as the NC cells differentiate.
###end p 55
###begin title 56
FGF signaling is unlikely to be involved in the NC differentiation pathway targeted by U0126
###end title 56
###begin p 57
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 359 367 359 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf3 </italic>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 </italic>
###xml 598 603 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 </italic>
###xml 610 614 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ace </italic>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
We examined FGFs as candidates for the upstream signal in the U0126-targeted NC differentiation process. FGFs are known to transmit their signals via the MAPK pathway [37] and have been implicated in the tail elongation process [60]. Unfortunately, they are also involved in D-V patterning, which begins prior to NC differentiation [39]. As a result of this, in vivo disruption of FGF signaling, using SU5402, or by using a combination of fgf3 and fgf8 antisense morpholinos (our unpublished data), produced a severe phenotype which probably masks its later function during NC differentiation. The fgf8 mutant ace also does not have an undulating NC, indicating it is not the upstream signal in this pathway [61]. However, since U0126 treatments seem to be able to eliminate Erk1/2 phosphorylation, and FGF signalling is transduced by the activity of these kinases, it seems puzzling that it only generates a mild phenotype compared to that expected from a complete lack of FGF signalling. We are aware of this contradiction and currently do not have a proper answer for it. The penetration of U0126 (5 hours after application there was still pErk1/2 present as detected by our Western blot analyses) could potentially also contribute the lack of early FGF-inhibition-like phenotype.
###end p 57
###begin p 58
It may also be possible that U0126 preferentially inhibits only Mek1 or Mek2, a hypothesis that cannot be tested due to lack of specific antibodies. Alternatively, some aspect of FGF signaling may be transduced by the activity of other molecules in addition to Mek1/2, and those parallel pathways are not inhibited by U0126.
###end p 58
###begin title 59
U0126 might inhibit the regulatory processes involved in the secretion of PNBM components
###end title 59
###begin p 60
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">laminin</italic>
###xml 128 145 128 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">coatomer complex </italic>
###xml 179 185 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP7a </italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
U0126 treatment phenocopies 3 groups of mutants identified in earlier large-scale mutagenesis screens [62,63]: the laminin, the coatomer complex (COPI) and the copper transporter ATP7a mutants [55,64,65]. They all have a shortened body axis and an undulating NC in which the chordamesoderm to mature NC transition process is arrested with similar abnormal persistence of mRNAs of structural and regulatory genes. Moreover, the structure of the PNBM is also perturbed in these mutants.
###end p 60
###begin p 61
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">laminin </italic>
###xml 17 43 17 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sleepy, grumpy and bashful</italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 340 348 340 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">laminin </italic>
laminin mutants (sleepy, grumpy and bashful), however, differ from U0126-treated embryos in several features. The inner layer of the PNBM, consisting mostly of laminins [51,52], is severely perturbed in these mutants, while in U0126 treated embryos laminin distribution and ultrastructure of the inner layer of the PNBM is entirely normal. laminin mutants also have neural defects, while neural development is normal in U0126 treated embryos. In addition, U0126 treatments lead to other defects not present in these mutants, such as the lack of pigmentation and the presence of apoptosis between 48 and 72 hpf. These results suggest that the role of Mek1/2 signaling in NC differentiation is downstream of, or parallel to laminin.
###end p 61
###begin p 62
###xml 18 32 18 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dopey, sneezy </italic>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">happy </italic>
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 85 94 85 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">calamity </italic>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
The COPI mutants (dopey, sneezy and happy [54]) and the copper metabolism disrupting calamity mutant [55] very closely resemble U0126-treated embryos with no additional or missing features. COPI is an essential part of the mammalian secretory machinery [66,67] which participates in retrograde transport from Golgi to the ER. The COPI complex comprised of 7 subunits and detailed mechanism of its action during this process is still not clear. It is very interesting to note however that according to a recent paper, recruitment of the other coatomer complex, COPII to ER export sites is regulated by phosphorylation via the p38/MAPK-pathway [68]. Due to the lack of specific antibodies for phosphorylated and dephosphorylated versions of the seven COPI subunits we could not examine the possibility that Mek1/2 phosphorylation is involved in regulation of this pathway but it is a promising direction for future research.
###end p 62
###begin title 63
###xml 68 77 <span type="species:ncbi:7955">zebrafish</span>
Interference with copper homeostasis phenocopies U0126-treatment in zebrafish embryos
###end title 63
###begin p 64
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">calamity </italic>
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP7a </italic>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 13 22 <span type="species:ncbi:7955">zebrafish</span>
###xml 472 478 <span type="species:ncbi:9606">humans</span>
The calamity zebrafish mutant (which bears a mutation on the copper transporter gene ATP7a and can also be phenocopied by copper chelating agents) [55,69] has a phenotype which is almost identical to that produced by U0126 treatment. Copper is an essential cofactor for the function of a variety of enzymes involved in iron oxidation, peptide amidation, cellular respiration and antioxidant defense [70]. The copper transporter Atp7a is also affected in Menkes disease in humans, which has skeletal defects among its symptoms [71].
###end p 64
###begin p 65
###xml 122 124 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 131 133 131 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 1090 1092 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
We can exclude the possibility of U0126 acting simply as a copper chelator, since pretreatment of U0126 solution with CuCl2 or CuSO4 did not prevent it from inducing NC defects in the embryos (not shown). Still, our TEM results demonstrate strong similarities between U0126-treated embryos and embryos in which copper metabolism is interfered with. These similarities include a milder decrease in collagen mass and disorganized, shorter fibers in the PNBM. This suggests that the copper metabolism pathway or at least part of it is regulated by the U0126 target process, although the nature of this interaction is unclear at present. Lysyl-oxidase is a copper dependent amin-oxidase normally expressed in the NC, and involved in the posttranslational, extracellular crosslinking of collagens and elastin [72,73]. This enzyme is regulated by FGF and Ras via the MAPK pathway and copper chelation results in its inactivation. [74,75]. Recently, it has also been shown that lysyl-oxidase activity regulates actin-filament formation, a process also affected in the NC of U0126-treated embryos [76]. Thus, the U0126 treatment may inferfere with these processes directly or indirectly via lysyl-oxidase activity and further studies will be necessary to address this question.
###end p 65
###begin title 66
Conclusion
###end title 66
###begin p 67
In summary, using pharmacological inhibition of Mek1/2 we demonstrated that:
###end p 67
###begin p 68
###xml 154 163 <span type="species:ncbi:7955">zebrafish</span>
i. U0126 treatment causes a consistent phenotype including lack of pigmentation and undulating NC which correlates with lack of Erk1/2 phosphorylation in zebrafish embryos.
###end p 68
###begin p 69
ii. U0126 disrupts the NC differentiation process during the chordamesoderm to mature NC transition step. As a result, structural and signaling genes fail to be downregulated during this process.
###end p 69
###begin p 70
iii. U0126-treatment also leads to abnormal differentiation and weakening of the PNBM. This leads to an inability of the PNBM to support the NC against its own hydrostatic pressure and results in undulations and bulges in its structure.
###end p 70
###begin p 71
iv. Using various methods of in vivo inhibition we excluded FGF as the potential upstream signal in the NC differentiation process affected by U0126.
###end p 71
###begin p 72
There are 2 major questions arising from our experiments:
###end p 72
###begin p 73
1. Is it possible that despite the overwhelming previously published evidence proving its specificity (and our ERK phosphorylation results) U0126 also might affect more than just MEK1/2?
###end p 73
###begin p 74
2. Is there a direct regulatory interaction between the COPI-mediated retrograde transport, the copper-dependent postranslational modifications by lysyl-oxidase and the U0126-targeted pathway?
###end p 74
###begin p 75
###xml 147 174 147 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crash test dummy, leviathan</italic>
The answer to these questions might surface through the cloning and identification of further uncharacterized mutants with similar phenotypes (ie. crash test dummy, leviathan). Alternatively, the identification of further pathway-specific chemicals in large-scale pharmacological screens which cause similar developmental defects could help in elucidating this phenomenon.
###end p 75
###begin title 76
Methods
###end title 76
###begin title 77
Fish maintainance and MEK1/2-inhibitor treatments
###end title 77
###begin p 78
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 11 22 <span type="species:ncbi:7955">Danio rerio</span>
Zebrafish (Danio rerio) were maintained under standard conditions [77]. Embryos were collected from wild-type (wik strain) crossings and kept at 28.5 C. Developmental stages were identified based on [78]. U0126 (Promega, V1121) was dissolved according to suppliers information (10 mM in DMSO). Up to 50 embryos were treated in 12-well plates with the appropriate concentration of U0126 diluted from stock in fish water. Embryos were kept in the solution until fixation. 10 mM stock solutions of U0124 (Santa Cruz Biochemicals) and PD98059 (Calbiochem) were made using DMSO. Embryos were treated as per U0126 with the appropriate concentrations of the drug (100 muM for U0124; 20, 25 and 30 muM for PD98059). U0124 was dissolved in 2% DMSO fish water as it precipitated otherwise, the appropriate control was used to ensure no effect of the high DMSO treatment.
###end p 78
###begin title 79
In situ hybridizations, TUNEL stainings
###end title 79
###begin p 80
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
Probe synthesis and whole mount in situ hybridizations (WISH) were carried out as described previously [79] using DIG labeling kit and NBT/BCIP developing solution from LaRoche. Two-color WISH was done using DIG and Fluorescein labelled probes recognized by the proper Fab fragments linked to alkaline phosphatase enzymes. The first probe was developed with NBT (La Roche) then fixed, washed in PBST (PBS w. 0.1% Tween20), the antibody destroyed in 0.2 M glycine solution washed again with PBST, blocked and incubated with the anti-Fluorescein-AP linked Fab fragment. After extensive washing this Ab was developed using INT/BCIP solution (La Roche).
###end p 80
###begin p 81
TUNEL stainings were carried out according to manufacturer's recommendation (Apoptaq kit, Chemicon)
###end p 81
###begin title 82
Immunhistochemistry, Bodipy-ceramide, phalloidin-sytox stainings and microscopy
###end title 82
###begin p 83
###xml 303 305 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
Standard procedures of whole mount immunhistochemistry were carried out using alpha-Acetylated tubulin Ab from (Sigma; 1:1000), alpha-phospho-histone3 Ab (Upstate; 1:400) and alpha-laminin (Sigma; 1:400) alpha-pERK1/2 (Sigma; 1:250). In vivo Bodipy-ceramide stainings were done as previously described [80]. Alexa568-conjugated phalloidin and Sytox-green (both Molecular Probes) stainings were carried out on PFA-fixed embryos according to manufacturers' protocols. All stained embryos were mounted on a slide with a coverslip and photographed on a Leica TCS2 confocal microscope.
###end p 83
###begin p 84
###xml 140 141 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 250 258 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">en bloc </italic>
For electron microscopy embryos were fixed in 2% paraformaldehyde, 2% gluteraldehyde in 0.1 M sodium cacodylate buffer (pH 7.3) with 2% CaCl2. Following postfixation in cacodylate buffered 1% w/v osmium tetraoxide (OsO4) (Johnson-Matthey) tissue was en bloc stained in 2% w/v uranyl acetate and embedded in medium Agar 100 epoxy resin (Agar Scientific). Ultrathin sections (80-90 nm) contrasted with saturated uranyl acetate solution and lead-citrate were examined and photographed using a JEOL1010 electron microscope.
###end p 84
###begin title 85
SDS-PAGE/Western Blotting
###end title 85
###begin p 86
###xml 263 268 <span type="species:ncbi:10090">mouse</span>
Protein was extracted by homogenisation of deyolked embryos, 7.5 mug of protein was seperated using 10% polyacrylamide gels, followed by transfer onto PVDF membrane (Amersham). The pERK1/2 antibody was the same as for immunohistochemistry applied here at 1:5000, mouse anti-gamma tubulin (Sigma; 1:10,000) was the loading control. Peroxidase activity from HRP-conjugated secondaries (Sigma) was detected using an ECL detection kit (Amersham).
###end p 86
###begin title 87
List of Abbreviations
###end title 87
###begin p 88
###xml 575 584 <span type="species:ncbi:7955">zebrafish</span>
Ab: antibody; C-E: convergent-extension; COPI: coatomer complex I; DIG: digoxygenin; ER: endoplasmatic reticulum; ERK: Extracellular signal regulated kinase; FP: floor plate; hh: hedgehog; hpf: hours post.fertilization; HC: hypochord; MAPK: Mitogen activated protein kinase; MEK: MAPK/ERK kinase; NC: notochord; PBS: phosphate buffered saline; PFA: parafolmaldehyde; PNBM: perinotochordal basement membrane; TEM: transmission eletron microscope; TUNEL: Terminal deoxynucleotidyl transferase dUTP Nick End Labeling; WISH: whole-mount in situ hybridization; wt: wild type; Zf: zebrafish.
###end p 88
###begin title 89
Authors' contributions
###end title 89
###begin p 90
TH did in situ hybridizations as well as electron microscopy and was involved in writing the manuscript. FC did the TUNEL stainings and in situ hybridizations and was involved in writing the manuscript. FE did U0126 inhibitor experiments, GS was involved in planning the experiments and writing the manuscript. ZL concieved the project, carried out large part of the experiments and wrote the manuscript.
###end p 90
###begin title 91
Acknowledgements
###end title 91
###begin p 92
This work was supported by grants from the Wellcome Trust and BBSRC to Stephen Wilson in whose lab much of the work was done and to whom the authors express their gratitude for his continous support and excellent critical comments throughout this work. The authors would also like to thank to the personnel of the UCL fish facility and to everyone who provided probes for in situ hybridization. Z.L. is a Bolyai fellow of the Hungarian Academy of Sciences. Grants supporting this project also included 509/2006 of the Hungarian Ministry of Health to Z. L.
###end p 92
###begin article-title 93
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish as a model system in developmental, toxicological and transgenic research
###end article-title 93
###begin article-title 94
###xml 110 119 <span type="species:ncbi:7955">zebrafish</span>
Hedgehog and Fgf signaling pathways regulate the development of tphR-expressing serotonergic raphe neurons in zebrafish embryos
###end article-title 94
###begin article-title 95
###xml 16 25 <span type="species:ncbi:7955">zebrafish</span>
Analysis of the zebrafish smoothened mutant reveals conserved and divergent functions of hedgehog activity
###end article-title 95
###begin article-title 96
###xml 80 89 <span type="species:ncbi:7955">zebrafish</span>
Interplay between FGF, one-eyed pinhead, and T-box transcription factors during zebrafish posterior development
###end article-title 96
###begin article-title 97
Specification of dorsal telencephalic character by sequential Wnt and FGF signaling
###end article-title 97
###begin article-title 98
###xml 75 84 <span type="species:ncbi:7955">zebrafish</span>
Time-dependent patterning of the mesoderm and endoderm by Nodal signals in zebrafish
###end article-title 98
###begin article-title 99
Biochemical suppression of small-molecule inhibitors: a strategy to identify inhibitor targets and signaling pathway components
###end article-title 99
###begin article-title 100
###xml 30 39 <span type="species:ncbi:7955">zebrafish</span>
In vivo drug discovery in the zebrafish
###end article-title 100
###begin article-title 101
Identification of a novel inhibitor of mitogen-activated protein kinase kinase
###end article-title 101
###begin article-title 102
Organization and regulation of mitogen-activated protein kinase signaling pathways
###end article-title 102
###begin article-title 103
p38 MAP kinases: beyond the stress response
###end article-title 103
###begin article-title 104
The JNK signal transduction pathway
###end article-title 104
###begin article-title 105
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions
###end article-title 105
###begin article-title 106
Functions of the MAPK family in vertebrate-development
###end article-title 106
###begin article-title 107
Distinct functions for ERKs?
###end article-title 107
###begin article-title 108
MAPK signalling: ERK5 versus ERK1/2
###end article-title 108
###begin article-title 109
###xml 63 72 <span type="species:ncbi:7955">zebrafish</span>
Characterization and expression patterns of the MAPK family in zebrafish
###end article-title 109
###begin article-title 110
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products
###end article-title 110
###begin article-title 111
Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2
###end article-title 111
###begin article-title 112
###xml 105 108 <span type="species:ncbi:10116">rat</span>
Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells
###end article-title 112
###begin article-title 113
###xml 40 43 <span type="species:ncbi:10116">rat</span>
ERK and p38 MAP kinase are required for rat renal development
###end article-title 113
###begin article-title 114
Activated extracellular signal-regulated kinases are necessary and sufficient to initiate tubulogenesis in renal tubular MDCK strain I cell cysts
###end article-title 114
###begin article-title 115
###xml 73 78 <span type="species:ncbi:9031">chick</span>
Control of the segmentation process by graded MAPK/ERK activation in the chick embryo
###end article-title 115
###begin article-title 116
Studies of the mitogen-activated protein kinases and phosphatidylinositol-3 kinase in the lens. 1. The mitogenic and stress responses
###end article-title 116
###begin article-title 117
Multiple signaling pathways regulate FGF-2-induced retinal ganglion cell neurite extension and growth cone guidance
###end article-title 117
###begin article-title 118
ERK signaling is required for eye-specific retino-geniculate segregation
###end article-title 118
###begin article-title 119
###xml 143 161 <span type="species:ncbi:7719">Ciona intestinalis</span>
A conserved role for the MEK signalling pathway in neural tissue specification and posteriorisation in the invertebrate chordate, the ascidian Ciona intestinalis
###end article-title 119
###begin article-title 120
Role of the FGF and MEK signaling pathway in the ascidian embryo
###end article-title 120
###begin article-title 121
Binary specification of nerve cord and notochord cell fates in ascidian embryos
###end article-title 121
###begin article-title 122
Structure and function of the notochord: an essential organ for chordate development
###end article-title 122
###begin article-title 123
Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway 10.1073/pnas.97.3.1113
###end article-title 123
###begin article-title 124
###xml 235 239 <span type="species:ncbi:10090">Mice</span>
Topical Treatment with Inhibitors of the Phosphatidylinositol 3'-Kinase/Akt and Raf/Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathways Reduces Melanoma Development in Severe Combined Immunodeficient Mice 10.1158/0008-5472.CAN-03-3327
###end article-title 124
###begin article-title 125
Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling
###end article-title 125
###begin article-title 126
A Synthetic Inhibitor of the Mitogen-Activated Protein Kinase Cascade 10.1073/pnas.92.17.7686
###end article-title 126
###begin article-title 127
Regulation of bidirectional melanosome transport by organelle bound MAP kinase
###end article-title 127
###begin article-title 128
###xml 55 64 <span type="species:ncbi:7955">zebrafish</span>
A role for FGF-8 in the dorsoventral patterning of the zebrafish gastrula
###end article-title 128
###begin article-title 129
###xml 75 84 <span type="species:ncbi:7955">zebrafish</span>
sprouty4 acts in vivo as a feedback-induced antagonist of FGF signaling in zebrafish
###end article-title 129
###begin article-title 130
Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling
###end article-title 130
###begin article-title 131
###xml 59 68 <span type="species:ncbi:7955">zebrafish</span>
Fgf signalling controls the dorsoventral patterning of the zebrafish embryo
###end article-title 131
###begin article-title 132
###xml 58 67 <span type="species:ncbi:7955">zebrafish</span>
Genetic analysis of dorsoventral pattern formation in the zebrafish: requirement of a BMP-like ventralizing activity and its dorsal repressor
###end article-title 132
###begin article-title 133
###xml 57 66 <span type="species:ncbi:7955">zebrafish</span>
Genes establishing dorsoventral pattern formation in the zebrafish embryo: the ventral specifying genes
###end article-title 133
###begin article-title 134
###xml 82 91 <span type="species:ncbi:7955">zebrafish</span>
Mutations affecting cell fates and cellular rearrangements during gastrulation in zebrafish
###end article-title 134
###begin article-title 135
###xml 136 145 <span type="species:ncbi:7955">zebrafish</span>
Functional interactions of genes mediating convergent extension, knypek and trilobite, during the partitioning of the eye primordium in zebrafish
###end article-title 135
###begin article-title 136
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension
###end article-title 136
###begin article-title 137
###xml 121 130 <span type="species:ncbi:7955">zebrafish</span>
Sonic hedgehog, secreted by amacrine cells, acts as a short-range signal to direct differentiation and lamination in the zebrafish retina 10.1242/dev.01247
###end article-title 137
###begin article-title 138
###xml 21 30 <span type="species:ncbi:7955">zebrafish</span>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
no tail (ntl) is the zebrafish homologue of the mouse T (Brachyury) gene
###end article-title 138
###begin article-title 139
###xml 69 78 <span type="species:ncbi:7955">zebrafish</span>
Induction of muscle pioneers and floor plate is distinguished by the zebrafish no tail mutation
###end article-title 139
###begin article-title 140
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Action of the Brachyury gene in mouse embryogenesis
###end article-title 140
###begin article-title 141
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Expression pattern of the mouse T gene and its role in mesoderm formation
###end article-title 141
###begin article-title 142
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos
###end article-title 142
###begin article-title 143
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish mutants identify an essential role for laminins in notochord formation
###end article-title 143
###begin article-title 144
Essential and overlapping roles for laminin alpha chains in notochord and blood vessel formation
###end article-title 144
###begin article-title 145
###xml 99 108 <span type="species:ncbi:7955">zebrafish</span>
Fgf signalling through MAPK cascade is required for development of the subpallial telencephalon in zebrafish embryos
###end article-title 145
###begin article-title 146
Differential requirements for COPI transport during vertebrate early development
###end article-title 146
###begin article-title 147
Atp7a determines a hierarchy of copper metabolism essential for notochord development
###end article-title 147
###begin article-title 148
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta
###end article-title 148
###begin article-title 149
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Mek2 is dispensable for mouse growth and development
###end article-title 149
###begin article-title 150
###xml 76 94 <span type="species:ncbi:7719">Ciona intestinalis</span>
Effects of U0126 and fibroblast growth factor on gene expression profile in Ciona intestinalis embryos as revealed by microarray analysis
###end article-title 150
###begin article-title 151
###xml 77 86 <span type="species:ncbi:7955">zebrafish</span>
Hedgehog signaling patterns the outgrowth of unpaired skeletal appendages in zebrafish
###end article-title 151
###begin article-title 152
###xml 47 56 <span type="species:ncbi:7955">zebrafish</span>
Analysis of FGF function in normal and no tail zebrafish embryos reveals separate mechanisms for formation of the trunk and the tail
###end article-title 152
###begin article-title 153
###xml 77 86 <span type="species:ncbi:7955">zebrafish</span>
Mutations affecting development of the midline and general body shape during zebrafish embryogenesis
###end article-title 153
###begin article-title 154
###xml 58 67 <span type="species:ncbi:7955">zebrafish</span>
A genetic screen for mutations affecting embryogenesis in zebrafish
###end article-title 154
###begin article-title 155
###xml 90 99 <span type="species:ncbi:7955">zebrafish</span>
###xml 101 112 <span type="species:ncbi:7955">Danio rerio</span>
The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio
###end article-title 155
###begin article-title 156
###xml 58 67 <span type="species:ncbi:7955">zebrafish</span>
###xml 69 80 <span type="species:ncbi:7955">Danio rerio</span>
Mutations affecting the formation of the notochord in the zebrafish, Danio rerio
###end article-title 156
###begin article-title 157
###xml 52 61 <span type="species:ncbi:7955">zebrafish</span>
Mutations affecting development of the notochord in zebrafish
###end article-title 157
###begin article-title 158
Getting into the Golgi
###end article-title 158
###begin article-title 159
Vesicular transport: the core machinery of COPI recruitment and budding
###end article-title 159
###begin article-title 160
p38 MAPK regulates COPII recruitment
###end article-title 160
###begin article-title 161
###xml 64 73 <span type="species:ncbi:7955">zebrafish</span>
Chemical genetics suggests a critical role for lysyl oxidase in zebrafish notochord morphogenesis
###end article-title 161
###begin article-title 162
A delicate balance: homeostatic control of copper uptake and distribution
###end article-title 162
###begin article-title 163
Menkes disease and Wilson disease: two sides of the same copper coin. Part I: Menkes disease
###end article-title 163
###begin article-title 164
Structural and functional diversity of lysyl oxidase and the LOX-like proteins
###end article-title 164
###begin article-title 165
Essential role of lysyl oxidases in notochord development
###end article-title 165
###begin article-title 166
Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells
###end article-title 166
###begin article-title 167
Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene
###end article-title 167
###begin article-title 168
Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex
###end article-title 168
###begin article-title 169
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish book
###end article-title 169
###begin article-title 170
###xml 39 48 <span type="species:ncbi:7955">zebrafish</span>
Stages of embryonic development of the zebrafish
###end article-title 170
###begin article-title 171
###xml 103 112 <span type="species:ncbi:7955">zebrafish</span>
hsp47 and hsp70 gene expression is differentially regulated in a stress- and tissue-specific manner in zebrafish embryos
###end article-title 171
###begin article-title 172
###xml 83 92 <span type="species:ncbi:7955">zebrafish</span>
parachute/n-cadherin is required for morphogenesis and maintained integrity of the zebrafish neural tube
###end article-title 172

